Biolase, Inc. (BIOL) News

Biolase, Inc. (BIOL): $0.95

-0.03 (-3.06%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter BIOL News Items

BIOL News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BIOL News Highlights

  • For BIOL, its 30 day story count is now at 2.
  • Over the past 4 days, the trend for BIOL's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest BIOL News From Around the Web

Below are the latest news stories about BIOLASE INC that investors may wish to consider to help them evaluate BIOL as an investment opportunity.

BIOLASE to Participate in the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 in New York

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11th Annual Benchmark Discovery One-on-One Investor Conference taking place December 1, 2022 in New York City. President and Chief Executive Office, John Beaver, and Chief Financial Officer, Jennifer Bright, will host one-on-one meetings with investors and analysts during the event.

Yahoo | November 14, 2022

BIOLASE DELIVERS 26% REVENUE GROWTH YEAR OVER YEAR IN THIRD QUARTER AND RAISES 2022 FULL YEAR REVENUE GUIDANCE

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2022.

Yahoo | November 10, 2022

BIOLASE, Inc to Report Third Quarter 2022 Results on November 10, 2022

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2022 financial and operating results on Thursday, November 10, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

Yahoo | October 27, 2022

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the progress and achievements of its borrower partners, including recent transactions and activities.

Yahoo | October 18, 2022

BIOLASE NAMES DR. RUSSELL MORROW AS CHIEF DENTAL OFFICER

BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the appointment of Russell Morrow, D.D.S. as Chief Dental Officer ("CDO"), effective November 1, 2022. Dr. Samuel Low, who has served as Chief Dental Officer since 2016, will be taking on a new role as Vice President, Clinical Strategic Alliances, where he will focus on building partnerships and growth with Dental Service Organizations (DSOs), universities and government institutions.

Yahoo | October 13, 2022

BIOLASE LAUNCHES RESEARCH GRANT PORTAL TO ACCELERATE CLINICAL STUDIES ON INNOVATIVE DENTAL LASER TECHNOLOGY

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it is inviting clinicians and researchers from around the world to submit research proposals via the Research Grant Portal at biolase.com/researchgrants.

Yahoo | October 5, 2022

BIOLASE DOCUSERIES, "TALK DENTAL TO ME" TO BE PRODUCED BY PROVIDENCE FILM GROUP

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has engaged Providence Film Group, a Valiant Eagle, Inc. (OTC: PSRU) subsidiary to produce a docuseries titled, "Talk Dental to Me."

Yahoo | September 22, 2022

BIOLASE ANNOUNCES DEVELOPMENT OF STRATEGIC PLAN TO PARTNER WITH POSTGRADUATE DENTAL SPECIALTY PROGRAMS ACROSS THE U.S.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced a strategic plan to partner with postgraduate dental specialty programs throughout North America, to expose new dentists to the benefits of Waterlase technology.

Yahoo | August 31, 2022

BIOLASE TO PARTICIPATE IN THE LAKE STREET 6TH ANNUAL BEST IDEAS GROWTH CONFERENCE SEPTEMBER 14, 2022

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to present at the Lake Street 6th Annual Best Ideas Growth Conference being held September 14, 2022. John Beaver, President and Chief Executive Officer, and Jennifer Bright, Chief Financial Officer, will present in-person to institutional investors and analysts during the event in New York City.

Yahoo | August 24, 2022

BIOLASE DELIVERS 34% REVENUE GROWTH YEAR OVER YEAR IN SECOND QUARTER

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30, 2022.

Yahoo | August 11, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7278 seconds.